Bristol-Myers (BMY) Q1 Loss Narrower Than Expected, Sales Beat

Bristol-Myers Squibb Company (BMY) reported an adjusted loss per share of $4.40, narrower than the Zacks Consensus Estimate of a loss of $4.53 per share. In the year-ago quarter, BMY posted adjusted earnings per share of $2.05.The year-over-year deterioration can be attributed to higher acquired IPRD costs, reflecting the impact of recent acquisitions and an increase in operating expenses.  The bottom-line was also negatively impacted due to higher interest expenses resulting from new debt issuance to fund ...